NurOwn, An Overview of the Stemcell Clinical Trial
Time & Location
About the Event
We are excited to host our next EverythingALS Patient Community Meeting: NurOwn, An Overview of the Stemcell Clinical Trial
We invite you to join us and other ALS patients and families to engage in a positive setting of collaboration and community.
The meeting will be Wednesday, October 21st at 4:00 pm PDT
-5:00pm Mountain Time
-6:00pm Central Time
-7:00pm Eastern Time
The meeting will be approximately 30-45mins long followed by an open forum.
Once you RSVP the Zoom details with password will be sent via email. Watch out for the email.
If you have any questions please email us at email@example.com
Our Guest Speaker, Dr. Namita Goyal, MD., is one of the Principal Investigators in the Stemcell NurOwn Phase 3 trial. Before the trial is unblinded and the top line results are released later this fall, Dr. Goyal will help us understand NurOwn's clinical development & the role of neuroinflammation in ALS.
Dr. Namita Goyal, MD, is a neurologist who specializes in neuromuscular diseases at UC Irvine Health, with board certifications in neurology, electrodiagnostic medicine and neuromuscular medicine. Her clinical interests include amyotrophic lateral sclerosis (ALS), muscular dystrophies, muscle disease, myasthenia gravis, and demyelinating neuropathies. She performs a number of diagnostic procedures including adult and pediatric electromyogram (EMG), single-fiber EMG and muscle biopsies.
Goyal completed a residency in neurology at University of Chicago Medical Center, followed by a fellowship in electromyography, clinical neurophysiology and neuromuscular disease at Harvard University’s Massachusetts General Hospital, where she subsequently served as a faculty member.
At UC Irvine, Goyal continues her work in neuromuscular medicine. In addition to evaluating and treating patients, she is a mentor to fellows and residents, serving as fellowship director for the Department of Neurology. She also is an investigator in several clinical trials involving neuromuscular diseases.
Find additional information on the clinical trials lead by Dr. Namita Goyal below:
We look forward to seeing you at the event!